Premature Clopidogrel Discontinuation after Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital

Houman Khalili, Rajeev Singh, Michael Wood, Anthony G Edwards, Mark Cooper, Colby Ayers, Elizabeth Moss, Jarett D Berry, Wanpen Vongpatanasin, James A de Lemos, Sandeep R Das

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Premature clopidogrel discontinuation is an important cause of stent thrombosis, myocardial infarction, and death after drug-eluting stent (DES) placement. Previous studies of clopidogrel nonadherence after DES placement have had short follow-up and have relied on self-reported adherence. All patients who underwent DES placement from January 2008 to December 2011 at a single safety-net hospital and received medications through the county-subsidized health plan were considered for inclusion; those with

Original languageEnglish (US)
Pages (from-to)522-525
Number of pages4
JournalAmerican Journal of Cardiology
Volume117
Issue number4
DOIs
StatePublished - Feb 15 2016

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Premature Clopidogrel Discontinuation after Drug-Eluting Stent Placement in a Large Urban Safety-Net Hospital'. Together they form a unique fingerprint.

  • Cite this